156 related articles for article (PubMed ID: 17097907)
1. [Management of in situ cervical adenocarcinoma].
Graesslin O; Dedecker F; Collinet P; Jouve E; Urbaniack D; Leroy JL; Boulanger JC; Quéreux C
Gynecol Obstet Fertil; 2006 Dec; 34(12):1178-84. PubMed ID: 17097907
[TBL] [Abstract][Full Text] [Related]
2. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
4. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
6. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
7. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
Tay EH; Yew WS; Ho TH
Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
[TBL] [Abstract][Full Text] [Related]
8. Is conservative treatment for adenocarcinoma in situ of the cervix safe?
Soutter WP; Haidopoulos D; Gornall RJ; McIndoe GA; Fox J; Mason WP; Flanagan A; Nicholas N; Barker F; Abrahams J; Lampert I; Sarhanis P
BJOG; 2001 Nov; 108(11):1184-9. PubMed ID: 11762660
[TBL] [Abstract][Full Text] [Related]
9. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
Dedecker F; Graesslin O; Bonneau S; Quéreux C
Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
[TBL] [Abstract][Full Text] [Related]
10. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
Schorge JO; Lea JS; Ashfaq R
J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
[TBL] [Abstract][Full Text] [Related]
11. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
[TBL] [Abstract][Full Text] [Related]
12. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
13. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
[TBL] [Abstract][Full Text] [Related]
14. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
[TBL] [Abstract][Full Text] [Related]
15. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
18. [Endocervical adenocarcinoma in situ. A histological entity to know].
Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
[TBL] [Abstract][Full Text] [Related]
19. Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?
Bryson P; Stulberg R; Shepherd L; McLelland K; Jeffrey J
Gynecol Oncol; 2004 May; 93(2):465-8. PubMed ID: 15099963
[TBL] [Abstract][Full Text] [Related]
20. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
